Hunan Nucien Pharmaceutical Co. Ltd.SSE: 688189

(688189)"Hunan Nucien Pharmaceutical Co., Ltd."Report for Q3 2026

· Issued by Hunan Nucien Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688189 · · 15 pages · Chinese

Summary by 6ix AI

The report highlights significant changes in financial metrics, including a notable increase in revenue due to higher sales volumes from selected products. It also mentions a decrease in research and development expenditures as the company prepares for upcoming projects.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Hunan Nucien Pharmaceutical Co. Ltd. on 6ix

Earlier from Hunan Nucien Pharmaceutical

All Hunan Nucien Pharmaceutical news releases